Register entry

AGC WAKASA CHEMICALS CO.,LTD.

Data as of · How to read this entry

Registered sites
1
Active NDC listings
1
Live patents
0
Countries
1
Base
Japan
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
AGC WAKASA CHEMICALS CO.,LTD.25-27-1, HANSEI, OBAMA, FUKUI 917-0044, Japan (JPN)Active ingredient (API) manufacture3005175594692032760
Catalogue

Marketed products

1
BrandGeneric nameForm / routeNDC
-Tafluprostsolution70390-0001BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
Compare

Comparable companies in Japan

Enquiry

Common questions

Is AGC WAKASA CHEMICALS CO.,LTD. FDA approved?
AGC WAKASA CHEMICALS CO.,LTD. holds 1 FDA-registered establishment in Japan. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are AGC WAKASA CHEMICALS CO.,LTD.'s drugs manufactured?
The FDA register lists OBAMA. Registered operations: active ingredient (API) manufacture.
What drugs does AGC WAKASA CHEMICALS CO.,LTD. make?
1 product is listed under AGC WAKASA CHEMICALS CO.,LTD. in the openFDA NDC Directory, most often as solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.